share_log

PharmaCyte Biotech | SC 13D: Statement of acquisition of beneficial ownership by individuals-PharmaCyte Biotech, Inc.(37.0%)

PharmaCyte Biotech | SC 13D:超過5%持股股東披露文件-PharmaCyte Biotech, Inc.(37.0%)

SEC announcement ·  2023/11/22 16:00
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息